Clinical Trial Update: Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

View source ↗

Summary

An update on an ongoing aHUS clinical trial registry sponsored by Alexion Pharmaceuticals, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic-Uremic Syndrome | Status: RECRUITING